Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.82% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.26% |
| 4 | Consumer Discretionary | 1.92% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
251
PUT
lululemon athletica
LULU
$14.3B
| $219M | 0.06% |
802,400
-127,400
| -14% | -$40.8M |
|
252
CALL
S&P Global
SPGI
$120B
| $218M | 0.06% |
646,428
-139,652
| -18% | -$49.8M |
|
253
US Bancorp
USB
$100B
| $217M | 0.06% |
4,725,338
+4,685,881
| +11,876% | +$234M |
|
254
PUT
Thermo Fisher Scientific
TMO
$224B
| $217M | 0.06% |
400,200
-263,800
| -40% | -$145M |
|
255
Uber
UBER
$160B
| $217M | 0.06% |
10,604,447
+1,130,397
| +12% | +$30M |
|
256
PUT
Domino's
DPZ
$11.8B
| $216M | 0.06% |
555,500
+318,300
| +134% | +$118M |
|
257
CALL
United States Oil Fund
USO
$1.8B
| $216M | 0.06% |
2,692,832
-1,961,708
| -42% | -$159M |
|
258
Illumina
ILMN
$29.1B
| $215M | 0.06% |
1,199,160
+378,361
| +46% | +$96.6M |
|
259
PUT
ASML
ASML
$691B
| $214M | 0.05% |
449,900
+39,000
| +9% | +$21.8M |
|
260
CALL
T-Mobile US
TMUS
$192B
| $212M | 0.05% |
1,575,200
+139,400
| +10% | +$18.2M |
|
261
PUT
Elevance Health
ELV
$84.7B
| $212M | 0.05% |
438,800
+273,100
| +165% | +$135M |
|
262
CALL
Twilio
TWLO
$39.3B
| $211M | 0.05% |
2,520,800
+959,300
| +61% | +$107M |
|
263
Kraft Heinz
KHC
$29.2B
| $211M | 0.05% |
5,524,466
+5,162,665
| +1,427% | +$207M |
|
264
Texas Instruments
TXN
$257B
| $209M | 0.05% |
1,357,603
+508,445
| +60% | +$85.5M |
|
265
CALL
Airbnb
ABNB
$111B
| $208M | 0.05% |
2,337,300
-1,012,400
| -30% | -$132M |
|
|
TWTR
266
PUT
DELISTED
Twitter, Inc.
TWTR
| $208M | 0.05% |
5,563,700
-2,124,700
| -28% | -$91.2M |
|
267
PUT
Freeport-McMoran
FCX
$96.4B
| $207M | 0.05% |
7,070,500
+771,300
| +12% | +$30.9M |
|
268
PUT
Merck
MRK
$322B
| $205M | 0.05% |
2,253,600
+306,700
| +16% | +$27.2M |
|
269
Eaton
ETN
$178B
| $205M | 0.05% |
1,628,390
+1,151,518
| +241% | +$161M |
|
270
CALL
NIO
NIO
$11.6B
| $205M | 0.05% |
9,419,000
+504,500
| +6% | +$9.26M |
|
271
PUT
Verizon
VZ
$196B
| $204M | 0.05% |
4,018,900
+203,100
| +5% | +$10.3M |
|
272
CALL
Expedia Group
EXPE
$38.5B
| $203M | 0.05% |
2,141,400
+783,700
| +58% | +$111M |
|
273
PUT
ARK Innovation ETF
ARKK
$6.38B
| $203M | 0.05% |
5,080,700
-490,100
| -9% | -$23.3M |
|
274
Fox Class A
FOXA
$26.1B
| $202M | 0.05% |
6,276,560
-1,153,264
| -16% | -$40.6M |
|
275
PUT
Intuitive Surgical
ISRG
$142B
| $202M | 0.05% |
1,005,700
+379,500
| +61% | +$89M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.